[{"Assets_0_Q3_USD":2610680000.0,"CommonStockSharesOutstanding_0_Q3_shares":48680054.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":99599000.0,"NetIncomeLoss_1_Q3_USD":-7177000.0,"NetIncomeLoss_3_Q3_USD":21162000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48637000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":49427000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":48637000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":48484000.0,"StockholdersEquity_0_Q3_USD":1784992000.0,"EarningsPerShareBasic_1_Q3_USD":-0.15,"EarningsPerShareBasic_3_Q3_USD":0.44,"EarningsPerShareDiluted_1_Q3_USD":-0.15,"EarningsPerShareDiluted_3_Q3_USD":0.43,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]